How Carvedilol activates β


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 11 2022
Historique:
received: 28 05 2022
accepted: 05 11 2022
entrez: 19 11 2022
pubmed: 20 11 2022
medline: 23 11 2022
Statut: epublish

Résumé

Carvedilol is among the most effective β-blockers for improving survival after myocardial infarction. Yet the mechanisms by which carvedilol achieves this superior clinical profile are still unclear. Beyond blockade of β

Identifiants

pubmed: 36402762
doi: 10.1038/s41467-022-34765-w
pii: 10.1038/s41467-022-34765-w
pmc: PMC9675828
doi:

Substances chimiques

Carvedilol 0K47UL67F2
Adrenergic beta-Antagonists 0
Receptors, Adrenergic, beta-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7109

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212313/Z/18/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Mol Pharmacol. 2021 Nov;100(5):513-525
pubmed: 34580163
Structure. 2020 Mar 3;28(3):371-377.e3
pubmed: 31978323
Mol Cell. 2018 May 3;70(3):473-487.e6
pubmed: 29727618
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94
pubmed: 19258456
Trends Biochem Sci. 2018 Jun;43(6):412-423
pubmed: 29636212
Circ Res. 1988 Jul;63(1):262-6
pubmed: 2898307
J Cell Biol. 2007 Feb 12;176(4):521-33
pubmed: 17296797
Lancet. 2003 Jul 5;362(9377):7-13
pubmed: 12853193
Elife. 2019 Oct 14;8:
pubmed: 31609201
Entropy (Basel). 2021 Aug 13;23(8):
pubmed: 34441183
Mol Pharmacol. 2000 Nov;58(5):1162-73
pubmed: 11040066
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8879-82
pubmed: 2827157
Am J Hypertens. 1998 Jan;11(1 Pt 2):15S-22S
pubmed: 9503102
J Biol Chem. 2001 Jun 1;276(22):19452-60
pubmed: 11279203
Am J Cardiol. 1990 Sep 25;66(9):21C-23C
pubmed: 1977302
JAMA. 1982 Mar 26;247(12):1707-14
pubmed: 7038157
J Comput Chem. 1999 Jun;20(8):786-798
pubmed: 35619462
J Biol Chem. 2006 Jan 13;281(2):1261-73
pubmed: 16280323
J Lab Autom. 2015 Apr;20(2):175-88
pubmed: 25532527
Eur Heart J. 2013 Jul;34(28):2159-219
pubmed: 23771844
Biochemistry. 1992 Mar 31;31(12):3193-7
pubmed: 1348186
Cardiovasc Res. 1998 Oct;40(1):146-55
pubmed: 9876327
Mol Cell. 2021 Nov 18;81(22):4605-4621.e11
pubmed: 34582793
Cell. 2017 Nov 16;171(5):1165-1175.e13
pubmed: 29149605
Chem Biol. 2008 Feb;15(2):128-36
pubmed: 18291317
Eur J Clin Pharmacol. 1978 Mar 17;13(1):1-4
pubmed: 25186
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1825-30
pubmed: 24449856
PLoS One. 2017 Apr 20;12(4):e0175642
pubmed: 28426733
J Vis Exp. 2012 Aug 20;(66):e4081
pubmed: 22929080
Mol Pharmacol. 1989 Mar;35(3):295-303
pubmed: 2564629
Nat Med. 2011 Jul 10;17(8):1003-9
pubmed: 21743453
Mol Cell. 2015 May 21;58(4):575-85
pubmed: 26000843
Sci Rep. 2019 Jan 24;9(1):439
pubmed: 30679635
BMC Cardiovasc Disord. 2013 Nov 14;13:100
pubmed: 24225056
Trends Pharmacol Sci. 2008 Aug;29(8):413-20
pubmed: 18606460
Am J Respir Cell Mol Biol. 2007 Feb;36(2):254-61
pubmed: 16980556
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):743-8
pubmed: 23267088
Nature. 1996 Oct 3;383(6599):447-50
pubmed: 8837779
Pharmacology. 1989;39(5):327-36
pubmed: 2575762
Chirality. 1989;1(4):265-70
pubmed: 2577144
Nat Protoc. 2011 Apr;6(4):427-38
pubmed: 21412271
Nat Commun. 2022 Jan 27;13(1):540
pubmed: 35087057
J Clin Invest. 2009 May;119(5):1312-21
pubmed: 19349687
Mol Cell Endocrinol. 2014 Feb 15;382(2):938-49
pubmed: 24275181
J Chem Theory Comput. 2016 Jan 12;12(1):405-13
pubmed: 26631602
Br J Pharmacol. 2009 Sep;158(1):50-60
pubmed: 19371331
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11406-11
pubmed: 13679574
J Biomol Screen. 2004 Jun;9(4):322-33
pubmed: 15191649
Mol Pharmacol. 2003 Dec;64(6):1357-69
pubmed: 14645666
J Biol Chem. 2002 Mar 15;277(11):9043-8
pubmed: 11782458
Nat Commun. 2018 Nov 9;9(1):4711
pubmed: 30413709
Bioorg Med Chem Lett. 2016 Jan 15;26(2):241-250
pubmed: 26707396
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
ACS Chem Biol. 2016 Feb 19;11(2):400-8
pubmed: 26569370
Curr Opin Struct Biol. 2014 Dec;29:143-51
pubmed: 25484000
J Mol Cell Cardiol. 2006 Sep;41(3):441-50
pubmed: 16765375
Trends Pharmacol Sci. 2007 Aug;28(8):374-81
pubmed: 17629959
J Chem Inf Model. 2019 Sep 23;59(9):3938-3945
pubmed: 31448910
Trends Pharmacol Sci. 1999 Jul;20(7):279-86
pubmed: 10390646
J Biol Chem. 1992 Apr 25;267(12):8558-64
pubmed: 1349018
FEBS Lett. 1984 Oct 29;176(2):473-8
pubmed: 6436059
Nat Commun. 2020 Jun 19;11(1):3033
pubmed: 32561830
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Oncogene. 2007 May 14;26(22):3122-42
pubmed: 17496911
Nat Med. 2010 Apr;16(4):347
pubmed: 20376007
Front Endocrinol (Lausanne). 2015 Nov 09;6:167
pubmed: 26617570
Nature. 2016 Jul 21;535(7612):448-52
pubmed: 27409812
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
iScience. 2020 Aug 21;23(9):101487
pubmed: 32891054
Nature. 2016 Mar 31;531(7596):665-8
pubmed: 27007854
Heliyon. 2020 May 15;6(5):e03960
pubmed: 32514478
Mol Cell. 2021 Oct 21;81(20):4165-4175.e6
pubmed: 34433090
J Biol Chem. 2018 May 11;293(19):7466-7473
pubmed: 29523687
Nature. 2011 Jan 13;469(7329):175-80
pubmed: 21228869
Br J Pharmacol. 2000 Jul;130(5):1131-9
pubmed: 10882399
Trends Biochem Sci. 2011 Sep;36(9):457-69
pubmed: 21764321
Front Cell Dev Biol. 2021 May 24;9:687489
pubmed: 34109182
Br J Pharmacol. 1982 Sep;77(1):105-14
pubmed: 6127131
Methods Mol Biol. 2011;746:425-40
pubmed: 21607873
Science. 2021 Mar 12;371(6534):
pubmed: 33479120
Sci Signal. 2017 Jun 20;10(484):
pubmed: 28634209
J Biol Chem. 2003 Feb 21;278(8):6258-67
pubmed: 12473660
J Biol Chem. 2006 Mar 17;281(11):7684-92
pubmed: 16407241
Nat Protoc. 2011 Oct 20;6(11):1748-60
pubmed: 22015845
Cell. 2016 Aug 11;166(4):907-919
pubmed: 27499021
J Chem Theory Comput. 2009 Jun 9;5(6):1632-9
pubmed: 26609855
Br J Pharmacol. 2008 Feb;153(4):751-9
pubmed: 18193079
J Biol Chem. 1999 Jun 11;274(24):16701-8
pubmed: 10358009
Int J Mol Sci. 2020 Jan 14;21(2):
pubmed: 31947522
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6516-20
pubmed: 6935665
Mol Pharmacol. 2006 Nov;70(5):1575-84
pubmed: 16901982
Circulation. 2004 Jan 20;109(2):201-6
pubmed: 14707020
Nature. 2017 Oct 26;550(7677):543-547
pubmed: 29045395
Nat Rev Drug Discov. 2006 Dec;5(12):993-6
pubmed: 17139284
Cell. 2019 Jun 13;177(7):1933-1947.e25
pubmed: 31160049
Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):844-852
pubmed: 31402328
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12435-12443
pubmed: 32414934
Nat Commun. 2019 Mar 19;10(1):1261
pubmed: 30890705
Cell. 2017 Jul 27;170(3):457-469.e13
pubmed: 28753425
Br J Pharmacol. 2016 Jul;173(14):2195-207
pubmed: 27155948
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Science. 2020 Feb 21;367(6480):881-887
pubmed: 32079767
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2562-2567
pubmed: 28223524
Nature. 2018 May;557(7705):452-456
pubmed: 29720655
Science. 2010 Mar 26;327(5973):1653-7
pubmed: 20185685
Mol Pharmacol. 2021 Dec;100(6):568-579
pubmed: 34561298
Nat Commun. 2022 Jan 25;13(1):487
pubmed: 35078997
Mol Pharmacol. 2021 Oct;100(4):388-405
pubmed: 34341099
Mol Pharmacol. 2003 Jun;63(6):1312-21
pubmed: 12761341
Rev Port Cardiol. 2001 Apr;20(4):383-99
pubmed: 11433884
Proc Natl Acad Sci U S A. 1978 Dec;75(12):5746-50
pubmed: 16592590
Pharmacol Rev. 1991 Jun;43(2):203-42
pubmed: 1677200
Lancet. 2001 May 5;357(9266):1385-90
pubmed: 11356434
J Biomol Screen. 2015 Aug;20(7):849-57
pubmed: 25851033
Commun Biol. 2018 Aug 7;1:105
pubmed: 30271985
J Biol Chem. 2000 Jul 28;275(30):23120-6
pubmed: 10770944
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
J Biol Chem. 2000 Jun 2;275(22):17201-10
pubmed: 10748214
J Biol Chem. 2008 Nov 14;283(46):31840-8
pubmed: 18801735
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2449-54
pubmed: 11226259
Sci Signal. 2018 Jan 09;11(512):
pubmed: 29317519
J Biol Chem. 1994 Jul 15;269(28):18448-52
pubmed: 7518433
J Biol Chem. 2016 Dec 30;291(53):27147-27159
pubmed: 27852822
Science. 2003 Apr 4;300(5616):87-91
pubmed: 12677058
J Biol Chem. 1997 Sep 19;272(38):23871-9
pubmed: 9295336
J Biol Chem. 2019 Apr 12;294(15):5747-5758
pubmed: 30745359
Sci Signal. 2020 Mar 31;13(625):
pubmed: 32234959
Cell. 2017 Jul 27;170(3):414-427
pubmed: 28753422
J Biol Chem. 2005 Mar 11;280(10):9528-35
pubmed: 15634674
Br J Pharmacol. 1970 Nov;40(3):373-81
pubmed: 4395742
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62
pubmed: 17925438
Br J Pharmacol. 2011 Mar;162(6):1439-52
pubmed: 21175569
Eur J Clin Pharmacol. 1990;38 Suppl 2:S82-8
pubmed: 1974511
EMBO J. 1988 Nov;7(11):3331-6
pubmed: 2905261
Protein Eng Des Sel. 2016 Dec;29(12):583-594
pubmed: 27672048
Circ Res. 2015 Apr 10;116(8):1304-11
pubmed: 25688144
Br J Pharmacol Chemother. 1968 Jan;32(1):201-18
pubmed: 4384337
Cell. 2020 Dec 23;183(7):1813-1825.e18
pubmed: 33296703
Nat Methods. 2008 Aug;5(8):695-702
pubmed: 18641657
World J Biol Chem. 2018 Dec 12;9(3):25-35
pubmed: 30595812
Nat Commun. 2018 Jan 23;9(1):341
pubmed: 29362459

Auteurs

Tobias Benkel (T)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.
Research Training Group 1873, University of Bonn, 53127, Bonn, Germany.

Mirjam Zimmermann (M)

InterAx Biotech AG, 5234, Villigen, Switzerland.

Julian Zeiner (J)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.

Sergi Bravo (S)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.

Nicole Merten (N)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.

Victor Jun Yu Lim (VJY)

Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany.

Edda Sofie Fabienne Matthees (ESF)

Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany.

Julia Drube (J)

Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany.

Elke Miess-Tanneberg (E)

Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University of Jena, 07747, Jena, Germany.

Daniela Malan (D)

Institute of Physiology I, Medical Faculty, University of Bonn, 53115, Bonn, Germany.

Martyna Szpakowska (M)

Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg.

Stefania Monteleone (S)

Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany.

Jak Grimes (J)

Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK.

Zsombor Koszegi (Z)

Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK.

Yann Lanoiselée (Y)

Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK.

Shannon O'Brien (S)

Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK.

Nikoleta Pavlaki (N)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Nadine Dobberstein (N)

InterAx Biotech AG, 5234, Villigen, Switzerland.

Asuka Inoue (A)

Graduate School of Pharmaceutical Science, Tohoku University, Sendai, 980-8578, Japan.

Viacheslav Nikolaev (V)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Davide Calebiro (D)

Institute of Metabolism and Systems Research and Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham, Birmingham, B15 2TT, UK.

Andy Chevigné (A)

Department of Infection and Immunity, Luxembourg Institute of Health (LIH), L-4354, Esch-sur-Alzette, Luxembourg.

Philipp Sasse (P)

Institute of Physiology I, Medical Faculty, University of Bonn, 53115, Bonn, Germany.

Stefan Schulz (S)

Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University of Jena, 07747, Jena, Germany.
7TM Antibodies GmbH, 07745, Jena, Germany.

Carsten Hoffmann (C)

Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, Jena University Hospital, Friedrich Schiller University of Jena, 07745, Jena, Germany.

Peter Kolb (P)

Department of Pharmaceutical Chemistry, Philipps-University of Marburg, 35032, Marburg, Germany.

Maria Waldhoer (M)

InterAx Biotech AG, 5234, Villigen, Switzerland.
Ikherma Consulting Ltd, Hitchin, SG4 0TY, UK.

Katharina Simon (K)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.

Jesus Gomeza (J)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany.

Evi Kostenis (E)

Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, 53115, Bonn, Germany. kostenis@uni-bonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH